Codexis (STU:4QK) Cyclically Adjusted Revenue per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4QK Codexis Inc STU:4QK
57 GF Score
Price €1.18
GF Value €2.22
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Codexis Cyclically Adjusted Revenue per Share?

Codexis STU:4QK +2.89% 57 Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus rates STU:4QK with a GF Score™ of 57/100 and a GF Value™ of €2.22 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Codexis's adjusted revenue per share for the three months ended in Jun. 2026 was €0.141. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Codexis's average Cyclically Adjusted Revenue Growth Rate was -2.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Codexis was 0.70% per year. The lowest was -41.00% per year. And the median was -11.75% per year.

As of today (2026-09-20), Codexis's current stock price is €1.176. Codexis's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was . Codexis's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Codexis was 27.14. The lowest was 0.70. And the median was 2.85.


Codexis  (STU:4QK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Codexis was 27.14. The lowest was 0.70. And the median was 2.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Codexis Cyclically Adjusted Revenue per Share Related Terms


Codexis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Codexis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codexis Cyclically Adjusted Revenue per Share Chart

Codexis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Codexis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:4QK vs SPRB, CRBU, MENS: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Codexis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codexis Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codexis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Codexis's Cyclically Adjusted PS Ratio falls into.


STU:4QK
57GF Score
Codexis Inc STU:4QK
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Codexis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Codexis's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.141/333.9520*333.9520
=0.141

Current CPI (Jun. 2026) = 333.9520.

Codexis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.316 241.428 0.437
201612 0.225 241.432 0.311
201703 0.181 243.801 0.248
201706 0.199 244.955 0.271
201709 0.177 246.819 0.239
201712 0.365 246.524 0.494
201803 0.236 249.554 0.316
201806 0.215 251.989 0.285
201809 0.272 252.439 0.360
201812 0.261 251.233 0.347
201903 0.253 254.202 0.332
201906 0.200 256.143 0.261
201909 0.321 256.759 0.418
201912 0.287 256.974 0.373
202003 0.226 258.115 0.292
202006 0.230 257.797 0.298
202009 0.266 260.280 0.341
202012 0.292 260.474 0.374
202103 0.233 264.877 0.294
202106 0.328 271.696 0.403
202109 0.460 274.310 0.560
202112 0.330 278.802 0.395
202203 0.484 287.504 0.562
202206 0.552 296.311 0.622
202209 0.523 296.808 0.588
202212 0.455 296.797 0.512
202303 0.184 301.836 0.204
202306 0.290 305.109 0.317
202309 0.123 307.789 0.133
202312 0.355 306.746 0.386
202403 0.225 312.332 0.241
202406 0.105 314.175 0.112
202409 0.162 315.301 0.172
202412 0.247 315.605 0.261
202503 0.087 319.799 0.091
202506 0.158 322.561 0.164
202509 0.082 324.800 0.084
202512 0.368 324.054 0.379
202603 0.144 330.213 0.146
202606 0.141 333.952 0.141

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of € mean?
Codexis (STU:4QK) has a Cyclically Adjusted Revenue per Share of € as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Codexis and its competitors.
Is Codexis' Cyclically Adjusted Revenue per Share too high?
Codexis' current Cyclically Adjusted Revenue per Share is €. Overall, Codexis has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Codexis' Cyclically Adjusted Revenue per Share compare to SPRB and CRBU?
Codexis' Cyclically Adjusted Revenue per Share of € can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Codexis and its competitors. Codexis's current Cyclically Adjusted Revenue per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Codexis stock overvalued right now?
Based on GuruFocus' analysis, Codexis (STU:4QK) is currently considered Possible Value Trap. The stock's GF Value™ is €2.22, compared to a current price of €1.18 — trading 47% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €. Codexis' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Codexis (STU:4QK), the current Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Codexis (STU:4QK) Overvalued in 2026?

Based on GuruFocus' analysis, Codexis stock appears to be undervalued. The current stock price of €1.18 is trading 47% below its estimated GF Value™ of €2.22. GuruFocus considers Codexis to be Possible Value Trap.

Key valuation signals for STU:4QK:

  • Cyclically Adjusted Revenue per Share:
  • GF Value™: €2.22 vs. price of €1.18 (47% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the STU:4QK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Codexis Business Description

Other Exchanges CDXS:USA0I0X:UK
Address 200 Penobscot Drive, Redwood City, CA, USA, 94063
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
57GF Score

Get the complete analysis for STU:4QK

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.18
Price
€2.22
GF Value